| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.757 | 0.005 | 0.757 | Aldehyde oxidase inhibitor | 0.721 0.007 CID_6847 | ||
| 0.751 | 0.018 | 0.751 | Caspase 9 stimulant | 0.475 0.071 CID_6847 | ||
| 0.639 | 0.004 | 0.639 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.614 0.005 CID_6847 | ||
| 0.55 | 0.06 | 0.55 | Apoptosis agonist | 0.268 0.197 CID_6847 | ||
| 0.498 | 0.024 | 0.498 | Aryl hydrocarbon receptor agonist | 0.228 0.088 CID_6847 | ||
| 0.499 | 0.026 | 0.527 | GABA C receptor rho-3 antagonist | 0.527 0.019 CID_6847 | CID_6847 | |
| 0.474 | 0.004 | 0.566 | Porphobilinogen synthase inhibitor | 0.566 0.003 CID_6847 | CID_6847 | |
| 0.466 | 0.005 | 0.466 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | |||
| 0.432 | 0.005 | 0.432 | Aldehyde dehydrogenase inhibitor | 0.341 0.008 CID_6847 | ||
| 0.411 | 0.008 | 0.751 | Alpha-N-acetylglucosaminidase inhibitor | 0.751 0.003 CID_6847 | CID_6847 | |
| 0.359 | 0.003 | 0.359 | CYP2A6 inhibitor | 0.114 0.029 CID_6847 | ||
| 0.36 | 0.005 | 0.36 | 3C-like protease (Human coronavirus) inhibitor | 0.318 0.008 CID_6847 | ||
| 0.382 | 0.028 | 0.382 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.148 0.132 CID_6847 | ||
| 0.372 | 0.02 | 0.372 | Anesthetic general | 0.285 0.037 CID_6847 | ||
| 0.338 | 0.011 | 0.338 | Neurotrophic factor enhancer | 0.273 0.027 CID_6847 | ||
| 0.397 | 0.08 | 0.661 | 5 Hydroxytryptamine release inhibitor | 0.661 0.005 CID_6847 | CID_6847 | |
| 0.353 | 0.04 | 0.353 | DNA damaging | 0.225 0.097 CID_6847 | ||
| 0.341 | 0.03 | 0.494 | Peroxidase inhibitor | 0.494 0.01 CID_6847 | CID_6847 | |
| 0.355 | 0.045 | 0.355 | Antioxidant | 0.232 0.094 CID_6847 | ||
| 0.347 | 0.038 | 0.347 | Dyrk kinase inhibitor | |||
| 0.333 | 0.031 | 0.468 | 5 Hydroxytryptamine uptake stimulant | 0.468 0.005 CID_6847 | CID_6847 | |
| 0.349 | 0.059 | 0.349 | Caspase 3 stimulant | |||
| 0.367 | 0.078 | 0.367 | Calpain 2 inhibitor | 0.212 0.177 CID_6847 | ||
| 0.31 | 0.029 | 0.366 | Tyrosine 3 hydroxylase inhibitor | 0.366 0.013 CID_6847 | CID_6847 | |
| 0.276 | 0.007 | 0.332 | Histidine decarboxylase inhibitor | 0.332 0.005 CID_6847 | CID_6847 | |
| 0.273 | 0.006 | 0.273 | Estrogen receptor beta antagonist | 0.106 0.053 CID_6847 | ||
| 0.275 | 0.008 | 0.275 | 5 Hydroxytryptamine 3E antagonist | 0.221 0.035 CID_6847 | ||
| 0.328 | 0.062 | 0.363 | 5 Hydroxytryptamine release stimulant | 0.363 0.054 CID_6847 | CID_6847 | |
| 0.306 | 0.048 | 0.543 | Superoxide dismutase inhibitor | 0.543 0.01 CID_6847 | CID_6847 | |
| 0.338 | 0.081 | 0.338 | Transcription factor NF kappa B inhibitor | 0.305 0.091 CID_6847 | ||
| 0.251 | 0.006 | 0.251 | HIV-1 integrase (3'-Processing) inhibitor | 0.153 0.013 CID_6847 | ||
| 0.25 | 0.009 | 0.25 | Toll-Like receptor 2 antagonist | 0.194 0.027 CID_6847 | ||
| 0.259 | 0.019 | 0.43 | Succinate dehydrogenase inhibitor | 0.43 0.004 CID_6847 | CID_6847 | |
| 0.285 | 0.049 | 0.361 | DNA synthesis inhibitor | 0.361 0.028 CID_6847 | CID_6847 | |
| 0.242 | 0.007 | 0.242 | HIV-1 integrase (Strand Transfer) inhibitor | 0.135 0.014 CID_6847 | ||
| 0.311 | 0.078 | 0.315 | Apoptosis antagonist | 0.315 0.076 CID_6847 | CID_6847 | |
| 0.244 | 0.014 | 0.253 | Mannose-6-phosphate isomerase inhibitor | 0.253 0.011 CID_6847 | CID_6847 | |
| 0.241 | 0.014 | 0.477 | Ferrochelatase inhibitor | 0.477 0.003 CID_6847 | CID_6847 | |
| 0.25 | 0.025 | 0.252 | Phospholipase C inhibitor | 0.252 0.025 CID_6847 | CID_6847 | |
| 0.225 | 0.004 | 0.225 | Purinergic P2X2 antagonist | |||
| 0.268 | 0.049 | 0.268 | Calpain inhibitor | 0.196 0.117 CID_6847 | ||
| 0.225 | 0.007 | 0.225 | TRPA1 agonist | 0.219 0.008 CID_6847 | ||
| 0.245 | 0.029 | 0.245 | Melanin inhibitor | 0.19 0.045 CID_6847 | ||
| 0.33 | 0.114 | 0.409 | Antibacterial | 0.409 0.073 CID_6847 | CID_6847 | |
| 0.225 | 0.01 | 0.225 | Estrogen antagonist | 0.115 0.065 CID_6847 | ||
| 0.227 | 0.016 | 0.615 | GABA C receptor agonist | 0.615 0.003 CID_6847 | CID_6847 | |
| 0.301 | 0.091 | 0.386 | Calcium channel activator | 0.386 0.03 CID_6847 | CID_6847 | |
| 0.22 | 0.014 | 0.22 | GABA receptor agonist | 0.095 0.083 CID_6847 | ||
| 0.295 | 0.094 | 0.667 | Cholesterol antagonist | 0.667 0.011 CID_6847 | CID_6847 | |
| 0.202 | 0.003 | 0.202 | Granulocyte macrophage colony stimulating factor agonist | 0.149 0.005 CID_6847 | ||
| 0.314 | 0.116 | 0.595 | Histamine release inhibitor | 0.595 0.01 CID_6847 | CID_6847 | |
| 0.285 | 0.089 | 0.3 | 12-Lipoxygenase inhibitor | 0.3 0.08 CID_6847 | CID_6847 | |
| 0.255 | 0.06 | 0.255 | Pyruvate kinase inhibitor | 0.206 0.078 CID_6847 | ||
| 0.206 | 0.01 | 0.226 | Phosphofructokinase-1 inhibitor | 0.226 0.009 CID_6847 | CID_6847 | |
| 0.205 | 0.012 | 0.205 | Interleukin 8 antagonist | 0.138 0.043 CID_6847 | ||
| 0.202 | 0.01 | 0.202 | Papain-like protease (SARS coronavirus) inhibitor | 0.182 0.015 CID_6847 | ||
| 0.225 | 0.033 | 0.265 | Interferon gamma antagonist | 0.265 0.026 CID_6847 | CID_6847 | |
| 0.2 | 0.009 | 0.2 | Sphingosine 1-phosphate receptor 4 antagonist | 0.183 0.013 CID_6847 | ||
| 0.226 | 0.036 | 0.226 | Heat shock protein 90 alpha antagonist | 0.179 0.063 CID_6847 | ||
| 0.194 | 0.005 | 0.194 | CDC25B inhibitor | 0.146 0.007 CID_6847 | ||
| 0.202 | 0.018 | 0.383 | UDP-glucose 4-epimerase inhibitor | 0.383 0.006 CID_6847 | CID_6847 | |
| 0.195 | 0.013 | 0.338 | Alcohol dehydrogenase inhibitor | 0.338 0.005 CID_6847 | CID_6847 | |
| 0.192 | 0.011 | 0.192 | GABA A receptor agonist | |||
| 0.232 | 0.051 | 0.395 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.395 0.008 CID_6847 | CID_6847 | |
| 0.191 | 0.01 | 0.191 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.171 0.014 CID_6847 | ||
| 0.19 | 0.011 | 0.269 | Glutamate dehydrogenase inhibitor | 0.269 0.006 CID_6847 | CID_6847 | |
| 0.268 | 0.089 | 0.268 | Immunostimulant | 0.254 0.095 CID_6847 | ||
| 0.204 | 0.026 | 0.204 | Neurotrophic factor | 0.172 0.043 CID_6847 | ||
| 0.256 | 0.083 | 0.317 | Transcription factor STAT inhibitor | 0.317 0.047 CID_6847 | CID_6847 | |
| 0.235 | 0.064 | 0.235 | Psychostimulant | 0.199 0.08 CID_6847 | ||
| 0.18 | 0.01 | 0.18 | Transcription factor STAT6 inhibitor | 0.124 0.053 CID_6847 | ||
| 0.182 | 0.013 | 0.418 | Triose-phosphate isomerase inhibitor | 0.418 0.003 CID_6847 | CID_6847 | |
| 0.197 | 0.03 | 0.247 | GABA C receptor rho-2 antagonist | 0.247 0.012 CID_6847 | CID_6847 | |
| 0.257 | 0.09 | 0.347 | Insulysin inhibitor | 0.347 0.035 CID_6847 | CID_6847 | |
| 0.188 | 0.022 | 0.264 | Xanthine oxidase inhibitor | 0.264 0.011 CID_6847 | CID_6847 | |
| 0.237 | 0.074 | 0.237 | Free radical scavenger | 0.221 0.083 CID_6847 | ||
| 0.203 | 0.04 | 0.221 | Protein kinase stimulant | 0.221 0.035 CID_6847 | CID_6847 | |
| 0.168 | 0.006 | 0.168 | Sphingosine 1-phosphate receptor 4 agonist | 0.128 0.014 CID_6847 | ||
| 0.163 | 0.005 | 0.164 | Purinergic P2X1 antagonist | 0.164 0.005 CID_6847 | CID_6847 | |
| 0.213 | 0.057 | 0.213 | LIM domain kinase 1 inhibitor | 0.15 0.097 CID_6847 | ||
| 0.162 | 0.006 | 0.19 | GABA aminotransferase inhibitor | 0.19 0.005 CID_6847 | CID_6847 | |
| 0.189 | 0.036 | 0.195 | Monophenol monooxygenase inhibitor | 0.195 0.034 CID_6847 | CID_6847 | |
| 0.161 | 0.008 | 0.161 | Alpha tubulin antagonist | |||
| 0.189 | 0.038 | 0.189 | Alkaline phosphatase inhibitor | 0.162 0.052 CID_6847 | ||
| 0.212 | 0.061 | 0.283 | Insulin sensitizer | 0.283 0.02 CID_6847 | CID_6847 | |
| 0.216 | 0.065 | 0.228 | Nitric-oxide synthase stimulant | 0.228 0.051 CID_6847 | CID_6847 | |
| 0.158 | 0.011 | 0.158 | Estrogen receptor alpha antagonist | 0.084 0.043 CID_6847 | ||
| 0.165 | 0.018 | 0.202 | Ca2+-transporting ATPase inhibitor | 0.202 0.003 CID_6847 | CID_6847 | |
| 0.167 | 0.02 | 0.284 | HIV-1 integrase (Overall Integration) inhibitor | 0.284 0.004 CID_6847 | CID_6847 | |
| 0.151 | 0.005 | 0.151 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.11 0.009 CID_6847 | ||
| 0.22 | 0.074 | 0.287 | RNA-directed DNA polymerase inhibitor | 0.287 0.034 CID_6847 | CID_6847 | |
| 0.153 | 0.01 | 0.77 | Alcohol oxidase inhibitor | 0.77 0.003 CID_6847 | CID_6847 | |
| 0.208 | 0.065 | 0.208 | Nitric oxide antagonist | 0.132 0.115 CID_6847 | ||
| 0.157 | 0.015 | 0.157 | Thioredoxin inhibitor | |||
| 0.186 | 0.045 | 0.186 | MAO inhibitor | |||
| 0.163 | 0.026 | 0.182 | Mucolytic | 0.182 0.018 CID_6847 | CID_6847 | |
| 0.144 | 0.007 | 0.144 | Elastase 1 inhibitor | 0.085 0.031 CID_6847 | ||
| 0.157 | 0.022 | 0.157 | Beta glucuronidase inhibitor | 0.132 0.036 CID_6847 | ||
| 0.184 | 0.05 | 0.215 | Arachidonic acid antagonist | 0.215 0.02 CID_6847 | CID_6847 | |
| 0.16 | 0.026 | 0.168 | Protein kinase C gamma inhibitor | 0.168 0.023 CID_6847 | CID_6847 | |
| 0.157 | 0.024 | 0.309 | Adenylate kinase inhibitor | 0.309 0.006 CID_6847 | CID_6847 | |
| 0.174 | 0.041 | 0.174 | Toll-Like receptor antagonist | |||
| 0.156 | 0.025 | 0.419 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.419 0.004 CID_6847 | CID_6847 | |
| 0.18 | 0.049 | 0.18 | Heat shock protein 90 antagonist | 0.133 0.093 CID_6847 | ||
| 0.15 | 0.021 | 0.23 | DOPA decarboxylase inhibitor | 0.23 0.004 CID_6847 | CID_6847 | |
| 0.161 | 0.036 | 0.33 | Cystathionine beta-synthase inhibitor | 0.33 0.008 CID_6847 | CID_6847 | |
| 0.144 | 0.021 | 0.15 | Anabolic | 0.15 0.018 CID_6847 | CID_6847 | |
| 0.147 | 0.025 | 0.304 | Creatine kinase inhibitor | 0.304 0.004 CID_6847 | CID_6847 | |
| 0.27 | 0.149 | 0.27 | 15-Lipoxygenase inhibitor | 0.259 0.158 CID_6847 | ||
| 0.196 | 0.076 | 0.232 | Histone acetyltransferase inhibitor | 0.232 0.035 CID_6847 | CID_6847 | |
| 0.158 | 0.04 | 0.158 | Antibacterial (Helicobacter pylori) | 0.145 0.05 CID_6847 | ||
| 0.152 | 0.036 | 0.152 | MAO B inhibitor | |||
| 0.131 | 0.016 | 0.131 | Aromatase inhibitor | 0.058 0.043 CID_6847 | ||
| 0.155 | 0.042 | 0.175 | Adenylate cyclase inhibitor | 0.175 0.032 CID_6847 | CID_6847 | |
| 0.121 | 0.007 | 0.184 | CD45 antagonist | 0.184 0.005 CID_6847 | CID_6847 | |
| 0.165 | 0.052 | 0.179 | CF transmembrane conductance regulator agonist | 0.179 0.037 CID_6847 | CID_6847 | |
| 0.115 | 0.005 | 0.115 | Glucose-6-phosphate translocase inhibitor | |||
| 0.136 | 0.028 | 0.256 | GABA C receptor rho-1 antagonist | 0.256 0.004 CID_6847 | CID_6847 | |
| 0.142 | 0.035 | 0.26 | GABA C receptor antagonist | 0.26 0.005 CID_6847 | CID_6847 | |
| 0.222 | 0.116 | 0.327 | Gastrin inhibitor | 0.327 0.018 CID_6847 | CID_6847 | |
| 0.142 | 0.036 | 0.199 | Photosensitizer | 0.199 0.013 CID_6847 | CID_6847 | |
| 0.15 | 0.046 | 0.189 | Cathepsin H inhibitor | 0.189 0.026 CID_6847 | CID_6847 | |
| 0.142 | 0.039 | 0.169 | Expectorant | 0.169 0.029 CID_6847 | CID_6847 | |
| 0.108 | 0.005 | 0.108 | Catechol O-methyltransferase inhibitor | |||
| 0.156 | 0.054 | 0.177 | Adenylate cyclase stimulant | 0.177 0.029 CID_6847 | CID_6847 | |
| 0.128 | 0.028 | 0.128 | Protein kinase C zeta inhibitor | 0.089 0.067 CID_6847 | ||
| 0.124 | 0.023 | 0.163 | Ornithine decarboxylase inhibitor | 0.163 0.008 CID_6847 | CID_6847 | |
| 0.104 | 0.003 | 0.104 | Pregnane X receptor antagonist | 0.085 0.005 CID_6847 | ||
| 0.125 | 0.026 | 0.3 | NADH dehydrogenase inhibitor | 0.3 0.006 CID_6847 | CID_6847 | |
| 0.161 | 0.065 | 0.294 | Phospholipase A2 inhibitor | 0.294 0.014 CID_6847 | CID_6847 | |
| 0.115 | 0.019 | 0.115 | Beta tubulin antagonist | |||
| 0.116 | 0.019 | 0.331 | Phenylalanine 4-hydroxylase inhibitor | 0.331 0.004 CID_6847 | CID_6847 | |
| 0.138 | 0.043 | 0.138 | 5 Hydroxytryptamine 3A agonist | 0.099 0.078 CID_6847 | ||
| 0.12 | 0.025 | 0.138 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.138 0.018 CID_6847 | CID_6847 | |
| 0.135 | 0.041 | 0.155 | Caspase 3 inhibitor | 0.155 0.025 CID_6847 | CID_6847 | |
| 0.155 | 0.062 | 0.263 | Amylase inhibitor | 0.263 0.025 CID_6847 | CID_6847 | |
| 0.21 | 0.119 | 0.21 | 5 Hydroxytryptamine 1E antagonist | 0.187 0.146 CID_6847 | ||
| 0.104 | 0.014 | 0.104 | Protease 3C (Human rhinovirus) inhibitor | 0.071 0.036 CID_6847 | ||
| 0.155 | 0.065 | 0.203 | Thiol protease inhibitor | 0.203 0.038 CID_6847 | CID_6847 | |
| 0.11 | 0.02 | 0.175 | D-Ala-D-Ala ligase inhibitor | 0.175 0.004 CID_6847 | CID_6847 | |
| 0.113 | 0.023 | 0.275 | Glutamate decarboxylase inhibitor | 0.275 0.004 CID_6847 | CID_6847 | |
| 0.095 | 0.006 | 0.095 | Squalene epoxidase inhibitor | 0.081 0.009 CID_6847 | ||
| 0.098 | 0.009 | 0.357 | Aconitate hydratase inhibitor | 0.357 0.002 CID_6847 | CID_6847 | |
| 0.116 | 0.027 | 0.148 | Macrophage migration inhibitory factor inhibitor | 0.148 0.016 CID_6847 | CID_6847 | |
| 0.129 | 0.041 | 0.407 | Carbonic anhydrase XV inhibitor | 0.407 0.004 CID_6847 | CID_6847 | |
| 0.165 | 0.077 | 0.425 | Mcl-1 antagonist | 0.425 0.009 CID_6847 | CID_6847 | |
| 0.124 | 0.037 | 0.124 | Ca(v)2.2 blocker | |||
| 0.1 | 0.017 | 0.1 | TRPA1 antagonist | 0.069 0.033 CID_6847 | ||
| 0.116 | 0.035 | 0.126 | Lanosterol 14 alpha demethylase inhibitor | 0.126 0.025 CID_6847 | CID_6847 | |
| 0.1 | 0.019 | 0.301 | Biliverdin reductase inhibitor | 0.301 0.003 CID_6847 | CID_6847 | |
| 0.116 | 0.035 | 0.116 | Androgen antagonist | |||
| 0.144 | 0.064 | 0.144 | Pregnane X receptor agonist | 0.14 0.074 CID_6847 | ||
| 0.113 | 0.032 | 0.216 | Carbonic anhydrase XIII inhibitor | 0.216 0.012 CID_6847 | CID_6847 | |
| 0.092 | 0.011 | 0.092 | Estradiol 17 beta-dehydrogenase inhibitor | 0.057 0.021 CID_6847 | ||
| 0.093 | 0.014 | 0.134 | AMPA receptor antagonist | 0.134 0.007 CID_6847 | CID_6847 | |
| 0.117 | 0.038 | 0.244 | Electrolyte absorption antagonist | 0.244 0.005 CID_6847 | CID_6847 | |
| 0.093 | 0.015 | 0.119 | Glutamate (mGluR7) antagonist | 0.119 0.005 CID_6847 | CID_6847 | |
| 0.117 | 0.04 | 0.129 | Prolactin inhibitor | 0.129 0.032 CID_6847 | CID_6847 | |
| 0.111 | 0.035 | 0.244 | Catalase inhibitor | 0.244 0.009 CID_6847 | CID_6847 | |
| 0.22 | 0.144 | 0.236 | Prostaglandin dehydrogenase inhibitor | 0.236 0.134 CID_6847 | CID_6847 | |
| 0.142 | 0.067 | 0.189 | Heat shock protein 70 antagonist | 0.189 0.009 CID_6847 | CID_6847 | |
| 0.09 | 0.017 | 0.1 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.1 0.014 CID_6847 | CID_6847 | |
| 0.124 | 0.05 | 0.22 | Aminopeptidase B inhibitor | 0.22 0.017 CID_6847 | CID_6847 | |
| 0.087 | 0.014 | 0.087 | Botulinum neurotoxin type A inhibitor | |||
| 0.106 | 0.033 | 0.154 | Glutamate receptor agonist | 0.154 0.016 CID_6847 | CID_6847 | |
| 0.092 | 0.019 | 0.092 | 5 Hydroxytryptamine 3 agonist | |||
| 0.116 | 0.044 | 0.144 | Sphingomyelinase inhibitor | 0.144 0.027 CID_6847 | CID_6847 | |
| 0.079 | 0.007 | 0.079 | Purinergic P2X4 antagonist | 0.047 0.029 CID_6847 | ||
| 0.088 | 0.016 | 0.088 | Exportin-1 inhibitor | 0.082 0.023 CID_6847 | ||
| 0.254 | 0.184 | 0.254 | Transcription factor inhibitor | |||
| 0.108 | 0.038 | 0.108 | Pim-3 kinase inhibitor | |||
| 0.091 | 0.022 | 0.142 | Peroxisome proliferator-activated receptor gamma antagonist | 0.142 0.006 CID_6847 | CID_6847 | |
| 0.116 | 0.048 | 0.116 | CDC-like kinase 3 inhibitor | |||
| 0.09 | 0.022 | 0.099 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.099 0.014 CID_6847 | CID_6847 | |
| 0.076 | 0.007 | 0.091 | Kainate receptor 2 antagonist | 0.091 0.005 CID_6847 | CID_6847 | |
| 0.088 | 0.021 | 0.088 | Protein kinase C beta inhibitor | 0.081 0.028 CID_6847 | ||
| 0.209 | 0.142 | 0.324 | Hypoxia-inducible factor 1 alpha inhibitor | 0.324 0.055 CID_6847 | CID_6847 | |
| 0.089 | 0.022 | 0.216 | Argininosuccinate synthase inhibitor | 0.216 0.007 CID_6847 | CID_6847 | |
| 0.076 | 0.01 | 0.076 | DNA-dependent protein kinase inhibitor | |||
| 0.192 | 0.126 | 0.228 | Spasmolytic | 0.228 0.101 CID_6847 | CID_6847 | |
| 0.095 | 0.029 | 0.095 | Benzodiazepine agonist | |||
| 0.086 | 0.021 | 0.141 | Xanthine dehydrogenase inhibitor | 0.141 0.008 CID_6847 | CID_6847 | |
| 0.098 | 0.034 | 0.098 | Na+ K+ transporting ATPase inhibitor | 0.084 0.047 CID_6847 | ||
| 0.084 | 0.02 | 0.171 | Glutamate (mGluR6) antagonist | 0.171 0.003 CID_6847 | CID_6847 | |
| 0.095 | 0.032 | 0.095 | Acetylcholine M4 receptor antagonist | |||
| 0.08 | 0.017 | 0.096 | Potassium channel intermediate-conductance Ca-activated blocker | 0.096 0.01 CID_6847 | CID_6847 | |
| 0.077 | 0.014 | 0.11 | Topoisomerase II beta inhibitor | 0.11 0.008 CID_6847 | CID_6847 | |
| 0.109 | 0.047 | 0.136 | Interleukin 1 beta converting enzyme inhibitor | 0.136 0.024 CID_6847 | CID_6847 | |
| 0.131 | 0.07 | 0.131 | Tubulin antagonist | |||
| 0.111 | 0.05 | 0.12 | Factor V inhibitor | 0.12 0.039 CID_6847 | CID_6847 | |
| 0.086 | 0.026 | 0.086 | Orexin receptor 1 antagonist | |||
| 0.086 | 0.026 | 0.104 | Phospholipase D inhibitor | 0.104 0.012 CID_6847 | CID_6847 | |
| 0.072 | 0.012 | 0.084 | Glucose-6-phosphate isomerase inhibitor | 0.084 0.008 CID_6847 | CID_6847 | |
| 0.101 | 0.041 | 0.142 | Glutamate release inhibitor | 0.142 0.012 CID_6847 | CID_6847 | |
| 0.073 | 0.014 | 0.073 | Prolyl endopeptidase inhibitor | 0.059 0.025 CID_6847 | ||
| 0.109 | 0.05 | 0.109 | Pim-1 kinase inhibitor | |||
| 0.087 | 0.028 | 0.087 | 5 Hydroxytryptamine 1D antagonist | |||
| 0.069 | 0.01 | 0.152 | Glutamate (mGluR4) antagonist | 0.152 0.004 CID_6847 | CID_6847 | |
| 0.067 | 0.009 | 0.067 | GABA B receptor antagonist | 0.052 0.018 CID_6847 | ||
| 0.093 | 0.035 | 0.106 | Estrogen-related receptor beta agonist | 0.106 0.018 CID_6847 | CID_6847 | |
| 0.072 | 0.015 | 0.072 | Nicotinic receptor alpha3 subunit antagonist | 0.044 0.03 CID_6847 | ||
| 0.09 | 0.034 | 0.169 | Aminopeptidase I inhibitor | 0.169 0.01 CID_6847 | CID_6847 | |
| 0.152 | 0.096 | 0.197 | Neurotensin receptor agonist | 0.197 0.036 CID_6847 | CID_6847 | |
| 0.068 | 0.013 | 0.077 | Immunoglobulin Fc receptor antagonist | 0.077 0.007 CID_6847 | CID_6847 | |
| 0.166 | 0.111 | 0.166 | Anticonvulsant | 0.144 0.136 CID_6847 | ||
| 0.059 | 0.005 | 0.059 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.093 | 0.039 | 0.126 | Glycine receptor antagonist | 0.126 0.015 CID_6847 | CID_6847 | |
| 0.06 | 0.006 | 0.079 | Angiotensin AT1 receptor antagonist | 0.079 0.003 CID_6847 | CID_6847 | |
| 0.065 | 0.011 | 0.169 | Glutamate (mGluR group III) antagonist | 0.169 0.003 CID_6847 | CID_6847 | |
| 0.089 | 0.036 | 0.089 | HIV-1 reverse transcriptase inhibitor | |||
| 0.08 | 0.028 | 0.124 | Carbamoyl phosphate synthetase inhibitor | 0.124 0.015 CID_6847 | CID_6847 | |
| 0.172 | 0.121 | 0.181 | Antiamyloidogenic | 0.181 0.114 CID_6847 | CID_6847 | |
| 0.196 | 0.145 | 0.27 | Lipoxygenase inhibitor | 0.27 0.087 CID_6847 | CID_6847 | |
| 0.075 | 0.024 | 0.195 | Acyl-CoA dehydrogenase inhibitor | 0.195 0.005 CID_6847 | CID_6847 | |
| 0.056 | 0.008 | 0.056 | Calcium release-activated channel blocker | |||
| 0.06 | 0.012 | 0.06 | Nicotinic receptor beta4 subunit antagonist | |||
| 0.189 | 0.14 | 0.234 | Neuropeptide Y2 antagonist | 0.234 0.073 CID_6847 | CID_6847 | |
| 0.096 | 0.048 | 0.096 | Antineoplastic antibiotic | |||
| 0.058 | 0.01 | 0.089 | Nerve growth factor antagonist | 0.089 0.004 CID_6847 | CID_6847 | |
| 0.096 | 0.049 | 0.161 | Histamine N-methyltransferase inhibitor | 0.161 0.011 CID_6847 | CID_6847 | |
| 0.059 | 0.011 | 0.059 | Alpha 1d adrenoreceptor agonist | 0.044 0.022 CID_6847 | ||
| 0.056 | 0.009 | 0.056 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.038 0.017 CID_6847 | ||
| 0.109 | 0.062 | 0.153 | Falcipain 3 inhibitor | 0.153 0.035 CID_6847 | CID_6847 | |
| 0.057 | 0.011 | 0.124 | GABA uptake inhibitor | 0.124 0.003 CID_6847 | CID_6847 | |
| 0.051 | 0.006 | 0.095 | Angiotensin II receptor antagonist | 0.095 0.003 CID_6847 | CID_6847 | |
| 0.087 | 0.043 | 0.087 | CC chemokine 5 receptor agonist | 0.082 0.057 CID_6847 | ||
| 0.148 | 0.104 | 0.236 | ATPase inhibitor | 0.236 0.018 CID_6847 | CID_6847 | |
| 0.116 | 0.072 | 0.139 | Alkylator | 0.139 0.052 CID_6847 | CID_6847 | |
| 0.046 | 0.003 | 0.046 | Complement factor 1s inhibitor | 0.035 0.005 CID_6847 | ||
| 0.112 | 0.07 | 0.136 | Microtubule formation inhibitor | 0.136 0.046 CID_6847 | CID_6847 | |
| 0.08 | 0.038 | 0.163 | Glycine receptor agonist | 0.163 0.005 CID_6847 | CID_6847 | |
| 0.067 | 0.025 | 0.067 | Bcl-xL inhibitor | 0.065 0.028 CID_6847 | ||
| 0.086 | 0.044 | 0.107 | Nicotinic alpha4beta2 receptor antagonist | 0.107 0.026 CID_6847 | CID_6847 | |
| 0.058 | 0.017 | 0.105 | Kainate receptor antagonist | 0.105 0.007 CID_6847 | CID_6847 | |
| 0.15 | 0.11 | 0.253 | Hepatoprotectant | 0.253 0.042 CID_6847 | CID_6847 | |
| 0.05 | 0.01 | 0.05 | Melatonin 2 agonist | |||
| 0.08 | 0.041 | 0.126 | GABA B receptor agonist | 0.126 0.006 CID_6847 | CID_6847 | |
| 0.099 | 0.061 | 0.111 | Glutamate (mGluR7) agonist | 0.111 0.041 CID_6847 | CID_6847 | |
| 0.063 | 0.026 | 0.202 | Dihydroorotate dehydrogenase inhibitor | 0.202 0.004 CID_6847 | CID_6847 | |
| 0.052 | 0.016 | 0.059 | Dopamine D5 agonist | 0.059 0.012 CID_6847 | CID_6847 | |
| 0.073 | 0.036 | 0.073 | Orexin receptor antagonist | |||
| 0.057 | 0.02 | 0.059 | Adenylate cyclase 1 inhibitor | 0.059 0.019 CID_6847 | CID_6847 | |
| 0.079 | 0.043 | 0.079 | Vanilloid 4 agonist | 0.079 0.043 CID_6847 | ||
| 0.177 | 0.142 | 0.335 | Interleukin agonist | 0.335 0.034 CID_6847 | CID_6847 | |
| 0.04 | 0.004 | 0.04 | Alpha 2a adrenoreceptor agonist | |||
| 0.076 | 0.042 | 0.117 | HIV-1 integrase inhibitor | 0.117 0.016 CID_6847 | CID_6847 | |
| 0.084 | 0.051 | 0.084 | Thioredoxin reductase inhibitor | 0.077 0.072 CID_6847 | ||
| 0.072 | 0.039 | 0.072 | 5 Hydroxytryptamine 1B antagonist | |||
| 0.06 | 0.026 | 0.101 | Nicotinic alpha3beta2 receptor antagonist | 0.101 0.007 CID_6847 | CID_6847 | |
| 0.057 | 0.023 | 0.057 | Potassium channel Kv1.3 blocker | |||
| 0.055 | 0.023 | 0.055 | Cholesterol esterase inhibitor | |||
| 0.06 | 0.028 | 0.09 | Thromboxane A2 antagonist | 0.09 0.01 CID_6847 | CID_6847 | |
| 0.123 | 0.091 | 0.123 | Nav1.6 sodium channel blocker | 0.119 0.098 CID_6847 | ||
| 0.061 | 0.028 | 0.102 | Dihydroorotate oxidase inhibitor | 0.102 0.005 CID_6847 | CID_6847 | |
| 0.207 | 0.175 | 0.354 | Vasodilator, coronary | 0.354 0.053 CID_6847 | CID_6847 | |
| 0.106 | 0.074 | 0.113 | Acetylcholine release stimulant | 0.113 0.061 CID_6847 | CID_6847 | |
| 0.154 | 0.124 | 0.165 | Focal adhesion kinase 2 inhibitor | 0.165 0.107 CID_6847 | CID_6847 | |
| 0.064 | 0.033 | 0.064 | Fibroblast growth factor 4 antagonist | |||
| 0.048 | 0.019 | 0.048 | Progesterone antagonist | |||
| 0.041 | 0.011 | 0.041 | Methionyl aminopeptidase 1 inhibitor | 0.037 0.015 CID_6847 | ||
| 0.039 | 0.01 | 0.039 | Kainate receptor 4 antagonist | |||
| 0.047 | 0.018 | 0.11 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.11 0.003 CID_6847 | CID_6847 | |
| 0.051 | 0.023 | 0.286 | Dihydroorotase inhibitor | 0.286 0.003 CID_6847 | CID_6847 | |
| 0.077 | 0.049 | 0.077 | Rho-associated kinase I inhibitor | |||
| 0.129 | 0.102 | 0.206 | Sphingosine 1-phosphate receptor 5 antagonist | 0.206 0.009 CID_6847 | CID_6847 | |
| 0.044 | 0.017 | 0.13 | Nicotinic acid receptor agonist | 0.13 0.004 CID_6847 | CID_6847 | |
| 0.038 | 0.012 | 0.056 | Glutamate (mGluR3) agonist | 0.056 0.004 CID_6847 | CID_6847 | |
| 0.054 | 0.028 | 0.101 | Phosphorylase inhibitor | 0.101 0.013 CID_6847 | CID_6847 | |
| 0.04 | 0.014 | 0.041 | Melatonin receptor 1A agonist | 0.041 0.013 CID_6847 | CID_6847 | |
| 0.14 | 0.115 | 0.301 | DNA methyltransferase I inhibitor | 0.301 0.026 CID_6847 | CID_6847 | |
| 0.043 | 0.018 | 0.086 | Glutamate (mGluR8) agonist | 0.086 0.004 CID_6847 | CID_6847 | |
| 0.059 | 0.033 | 0.098 | Thromboxane antagonist | 0.098 0.012 CID_6847 | CID_6847 | |
| 0.054 | 0.029 | 0.054 | Potassium channel (Inward rectifier) activator | |||
| 0.065 | 0.04 | 0.065 | Transcription factor RelA inhibitor | 0.064 0.042 CID_6847 | ||
| 0.04 | 0.015 | 0.062 | Tryptophan 5 hydroxylase inhibitor | 0.062 0.004 CID_6847 | CID_6847 | |
| 0.105 | 0.081 | 0.107 | Proteasome inhibitor | 0.107 0.079 CID_6847 | CID_6847 | |
| 0.129 | 0.105 | 0.318 | Hexokinase inhibitor | 0.318 0.009 CID_6847 | CID_6847 | |
| 0.044 | 0.02 | 0.127 | AMPA 4 receptor antagonist | 0.127 0.004 CID_6847 | CID_6847 | |
| 0.028 | 0.005 | 0.028 | Alpha 2c adrenoreceptor agonist | |||
| 0.044 | 0.02 | 0.135 | TRPM8 blocker | 0.135 0.005 CID_6847 | CID_6847 | |
| 0.051 | 0.028 | 0.051 | Potassium channel (ATP-sensitive) activator | |||
| 0.027 | 0.004 | 0.027 | Granulocyte colony stimulating factor receptor agonist | |||
| 0.04 | 0.017 | 0.04 | Purinergic P2X3 antagonist | |||
| 0.044 | 0.022 | 0.081 | 5-Alpha-reductase inhibitor | 0.081 0.012 CID_6847 | CID_6847 | |
| 0.027 | 0.005 | 0.027 | Follicle-stimulating hormone antagonist | |||
| 0.05 | 0.028 | 0.054 | Oleamide hydrolase inhibitor | 0.054 0.024 CID_6847 | CID_6847 | |
| 0.049 | 0.028 | 0.049 | Benzodiazepine antagonist | |||
| 0.03 | 0.009 | 0.063 | Glutamate (mGluR1a) agonist | 0.063 0.004 CID_6847 | CID_6847 | |
| 0.041 | 0.02 | 0.041 | Inosine monophosphate dehydrogenase inhibitor | |||
| 0.026 | 0.005 | 0.026 | Alpha 2b adrenoreceptor agonist | |||
| 0.044 | 0.023 | 0.075 | Kainate receptor agonist | 0.075 0.004 CID_6847 | CID_6847 | |
| 0.046 | 0.026 | 0.046 | Histamine H1 receptor agonist | |||
| 0.029 | 0.01 | 0.029 | Follicle-stimulating hormone agonist | |||
| 0.045 | 0.026 | 0.074 | Guanylate cyclase inhibitor | 0.074 0.004 CID_6847 | CID_6847 | |
| 0.044 | 0.025 | 0.044 | Heme oxygenase inhibitor | 0.044 0.025 CID_6847 | ||
| 0.111 | 0.093 | 0.139 | DNA repair enzyme inhibitor | 0.139 0.042 CID_6847 | CID_6847 | |
| 0.042 | 0.024 | 0.042 | Phenylethanolamine N methyltransferase inhibitor | |||
| 0.058 | 0.041 | 0.081 | Sphingosine 1-phosphate receptor 3 antagonist | 0.081 0.017 CID_6847 | CID_6847 | |
| 0.047 | 0.03 | 0.047 | Farnesyltransferase inhibitor | |||
| 0.102 | 0.085 | 0.208 | Cholesterol synthesis inhibitor | 0.208 0.025 CID_6847 | CID_6847 | |
| 0.039 | 0.022 | 0.039 | Orexin receptor 2 antagonist | |||
| 0.112 | 0.095 | 0.112 | Toll-Like receptor 9 antagonist | |||
| 0.025 | 0.009 | 0.025 | Imidazoline I1 receptor antagonist | |||
| 0.054 | 0.038 | 0.103 | DNA helicase inhibitor | 0.103 0.005 CID_6847 | CID_6847 | |
| 0.027 | 0.011 | 0.028 | Geranylgeranyltransferase inhibitor | 0.028 0.01 CID_6847 | CID_6847 | |
| 0.075 | 0.06 | 0.075 | Acetylcholine nicotinic antagonist | |||
| 0.039 | 0.024 | 0.042 | Vanilloid 3 antagonist | 0.042 0.018 CID_6847 | CID_6847 | |
| 0.026 | 0.011 | 0.026 | ICAM 1 antagonist | 0.023 0.017 CID_6847 | ||
| 0.052 | 0.037 | 0.12 | Ornithine carbamoyltransferase inhibitor | 0.12 0.013 CID_6847 | CID_6847 | |
| 0.049 | 0.034 | 0.058 | Dopamine beta hydroxylase inhibitor | 0.058 0.017 CID_6847 | CID_6847 | |
| 0.065 | 0.05 | 0.065 | Acetylcholine M5 receptor agonist | |||
| 0.026 | 0.011 | 0.034 | Kainate receptor 5 antagonist | 0.034 0.008 CID_6847 | CID_6847 | |
| 0.026 | 0.012 | 0.052 | Kainate receptor 1 antagonist | 0.052 0.005 CID_6847 | CID_6847 | |
| 0.057 | 0.042 | 0.067 | Glutamate (mGluR1) antagonist | 0.067 0.033 CID_6847 | CID_6847 | |
| 0.036 | 0.022 | 0.125 | Fumarate hydratase inhibitor | 0.125 0.004 CID_6847 | CID_6847 | |
| 0.043 | 0.029 | 0.043 | Leukocyte elastase inhibitor | |||
| 0.081 | 0.067 | 0.134 | 3C-Like protease (SARS coronavirus) inhibitor | 0.134 0.014 CID_6847 | CID_6847 | |
| 0.032 | 0.019 | 0.082 | AMPA 1 receptor antagonist | 0.082 0.007 CID_6847 | CID_6847 | |
| 0.052 | 0.039 | 0.065 | Alpha-mannosidase inhibitor | 0.065 0.021 CID_6847 | CID_6847 | |
| 0.235 | 0.222 | 0.516 | Calcium channel L-type activator | 0.516 0.022 CID_6847 | CID_6847 | |
| 0.037 | 0.025 | 0.037 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | |||
| 0.055 | 0.042 | 0.055 | 5 Hydroxytryptamine 7 agonist | |||
| 0.029 | 0.017 | 0.038 | LFA antagonist | 0.038 0.009 CID_6847 | CID_6847 | |
| 0.02 | 0.008 | 0.02 | Calcium-sensing receptor antagonist | |||
| 0.034 | 0.022 | 0.046 | Protein kinase (CK2) beta inhibitor | 0.046 0.009 CID_6847 | CID_6847 | |
| 0.191 | 0.18 | 0.191 | Thioredoxin glutathione reductase inhibitor | 0.186 0.184 CID_6847 | ||
| 0.151 | 0.139 | 0.151 | Growth factor agonist | |||
| 0.034 | 0.023 | 0.071 | Free fatty acid receptor 1 antagonist | 0.071 0.004 CID_6847 | CID_6847 | |
| 0.031 | 0.02 | 0.079 | AMPA 3 receptor antagonist | 0.079 0.004 CID_6847 | CID_6847 | |
| 0.061 | 0.051 | 0.061 | Aryl hydrocarbon receptor antagonist | |||
| 0.043 | 0.032 | 0.07 | AICAR transformylase inhibitor | 0.07 0.01 CID_6847 | CID_6847 | |
| 0.059 | 0.049 | 0.059 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.048 | 0.038 | 0.09 | Lysophosphatidic acid 3 receptor antagonist | 0.09 0.006 CID_6847 | CID_6847 | |
| 0.137 | 0.127 | 0.227 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.227 0.064 CID_6847 | CID_6847 | |
| 0.076 | 0.067 | 0.158 | Calcium antagonist | 0.158 0.02 CID_6847 | CID_6847 | |
| 0.034 | 0.025 | 0.142 | Retinoid X alpha receptor agonist | 0.142 0.003 CID_6847 | CID_6847 | |
| 0.219 | 0.211 | 0.235 | DNA polymerase beta inhibitor | 0.235 0.202 CID_6847 | CID_6847 | |
| 0.092 | 0.083 | 0.163 | AMP-activated protein kinase stimulant | 0.163 0.021 CID_6847 | CID_6847 | |
| 0.028 | 0.019 | 0.036 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.036 0.014 CID_6847 | CID_6847 | |
| 0.015 | 0.007 | 0.015 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.015 0.007 CID_6847 | ||
| 0.061 | 0.053 | 0.07 | Calcium channel P-type blocker | 0.07 0.027 CID_6847 | CID_6847 | |
| 0.084 | 0.076 | 0.358 | Uric acid excretion stimulant | 0.358 0.004 CID_6847 | CID_6847 | |
| 0.061 | 0.053 | 0.067 | Bcl2 antagonist | 0.067 0.046 CID_6847 | CID_6847 | |
| 0.084 | 0.076 | 0.084 | MAO A inhibitor | |||
| 0.07 | 0.063 | 0.07 | Potassium channel (Tandem pore domain) blocker | |||
| 0.033 | 0.026 | 0.033 | Estradiol 17 beta-dehydrogenase 2 inhibitor | |||
| 0.028 | 0.021 | 0.029 | Purinergic P2Y15 antagonist | 0.029 0.02 CID_6847 | CID_6847 | |
| 0.027 | 0.02 | 0.029 | Hedgehog signaling activator | 0.029 0.015 CID_6847 | CID_6847 | |
| 0.066 | 0.059 | 0.118 | Cathepsin G inhibitor | 0.118 0.028 CID_6847 | CID_6847 | |
| 0.015 | 0.009 | 0.04 | Angiotensin AT1B receptor antagonist | 0.04 0.003 CID_6847 | CID_6847 | |
| 0.016 | 0.01 | 0.016 | Purinergic P2Y1 agonist | |||
| 0.021 | 0.014 | 0.044 | Retinoid X beta receptor antagonist | 0.044 0.003 CID_6847 | CID_6847 | |
| 0.021 | 0.015 | 0.046 | Peroxisome proliferator-activated receptor alpha antagonist | 0.046 0.009 CID_6847 | CID_6847 | |
| 0.08 | 0.074 | 0.08 | Falcipain inhibitor | |||
| 0.138 | 0.132 | 0.138 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | |||
| 0.036 | 0.03 | 0.073 | Retinoid X receptor antagonist | 0.073 0.004 CID_6847 | CID_6847 | |
| 0.024 | 0.019 | 0.075 | Methionyl aminopeptidase 2 inhibitor | 0.075 0.004 CID_6847 | CID_6847 | |
| 0.033 | 0.027 | 0.04 | Calcium-independent phospholipase A2 inhibitor | 0.04 0.01 CID_6847 | CID_6847 | |
| 0.047 | 0.042 | 0.236 | Factor III inhibitor | 0.236 0.002 CID_6847 | CID_6847 | |
| 0.019 | 0.014 | 0.03 | 5-Alpha-reductase 2 inhibitor | 0.03 0.009 CID_6847 | CID_6847 | |
| 0.019 | 0.014 | 0.019 | Inosine monophosphate dehydrogenase 2 inhibitor | |||
| 0.086 | 0.081 | 0.279 | Carbonic anhydrase III inhibitor | 0.279 0.007 CID_6847 | CID_6847 | |
| 0.032 | 0.027 | 0.119 | Retinoid X receptor agonist | 0.119 0.004 CID_6847 | CID_6847 | |
| 0.015 | 0.01 | 0.015 | Antibiotic Tetracycline-like | |||
| 0.112 | 0.108 | 0.126 | Vanilloid 1 agonist | 0.126 0.074 CID_6847 | CID_6847 | |
| 0.032 | 0.028 | 0.063 | Retinoid X alpha receptor antagonist | 0.063 0.004 CID_6847 | CID_6847 | |
| 0.077 | 0.073 | 0.077 | Falcipain 2 inhibitor | |||
| 0.052 | 0.048 | 0.068 | Sphingosine 1-phosphate receptor 1 antagonist | 0.068 0.02 CID_6847 | CID_6847 | |
| 0.024 | 0.02 | 0.039 | Lysophosphatidic acid receptor 1 agonist | 0.039 0.006 CID_6847 | CID_6847 | |
| 0.042 | 0.038 | 0.064 | Thymidylate synthase inhibitor | 0.064 0.014 CID_6847 | CID_6847 | |
| 0.05 | 0.046 | 0.05 | Pim-2 kinase inhibitor | |||
| 0.054 | 0.051 | 0.054 | Alpha 2 adrenoreceptor agonist | |||
| 0.069 | 0.066 | 0.225 | Keratolytic | 0.225 0.006 CID_6847 | CID_6847 | |
| 0.021 | 0.018 | 0.037 | Protease (Human cytomegalovirus) inhibitor | 0.037 0.005 CID_6847 | CID_6847 | |
| 0.073 | 0.07 | 0.093 | MAP kinase kinase 7 inhibitor | 0.093 0.02 CID_6847 | CID_6847 | |
| 0.025 | 0.022 | 0.063 | Nicotinic acid receptor 2 antagonist | 0.063 0.003 CID_6847 | CID_6847 | |
| 0.011 | 0.01 | 0.012 | Integrin beta2 antagonist | 0.012 0.009 CID_6847 | CID_6847 | |
| 0.019 | 0.017 | 0.019 | Geranylgeranyltransferase I inhibitor | |||
| 0.052 | 0.05 | 0.052 | Protein kinase C theta inhibitor | |||
| 0.006 | 0.005 | 0.006 | CC chemokine 6 receptor agonist | |||
| 0.035 | 0.034 | 0.035 | Dopamine D3 agonist | |||
| 0.045 | 0.044 | 0.045 | Nicotinic receptor alpha4 subunit antagonist | |||
| 0.039 | 0.038 | 0.061 | Purinergic P2Y antagonist | 0.061 0.019 CID_6847 | CID_6847 | |
| 0.017 | 0.017 | 0.023 | Methylmalonyl-CoA mutase inhibitor | 0.023 0.005 CID_6847 | CID_6847 | |
| 0.079 | 0.079 | 0.09 | Bromodomain-containing protein 2 inhibitor | 0.09 0.055 CID_6847 | CID_6847 | |
| 0.084 | 0.085 | 0.129 | Urease inhibitor | 0.129 0.037 CID_6847 | CID_6847 | |
| 0.032 | 0.032 | 0.032 | AMPA receptor agonist | 0.032 0.031 CID_6847 | CID_6847 | |
| 0.023 | 0.024 | 0.035 | Vanilloid 2 agonist | 0.035 0.005 CID_6847 | CID_6847 | |
| 0.04 | 0.041 | 0.064 | Mannosidase inhibitor | 0.064 0.014 CID_6847 | CID_6847 | |
| 0.032 | 0.034 | 0.045 | Diamine oxidase inhibitor | 0.045 0.018 CID_6847 | CID_6847 | |
| 0.032 | 0.034 | 0.16 | Glutamate (mGluR3) antagonist | 0.16 0.004 CID_6847 | CID_6847 | |
| 0.052 | 0.055 | 0.131 | NMDA receptor glycine site agonist | 0.131 0.006 CID_6847 | CID_6847 | |
| 0.013 | 0.016 | 0.016 | Thromboxane A2 agonist | 0.016 0.01 CID_6847 | CID_6847 | |
| 0.027 | 0.029 | 0.034 | Sirtuin 2 inhibitor | 0.034 0.022 CID_6847 | CID_6847 | |
| 0.028 | 0.03 | 0.061 | ATP citrate lysase inhibitor | 0.061 0.005 CID_6847 | CID_6847 | |
| 0.038 | 0.041 | 0.065 | Geranyltranstransferase inhibitor | 0.065 0.01 CID_6847 | CID_6847 | |
| 0.07 | 0.072 | 0.09 | Sphingosine 1-phosphate receptor antagonist | 0.09 0.03 CID_6847 | CID_6847 | |
| 0.013 | 0.016 | 0.022 | 5-Alpha-reductase 1 inhibitor | 0.022 0.01 CID_6847 | CID_6847 | |
| 0.062 | 0.066 | 0.095 | MDM2 inhibitor | 0.095 0.009 CID_6847 | CID_6847 | |
| 0.011 | 0.014 | 0.024 | Human herpes virus 5 capsid protein P40 inhibitor | 0.024 0.004 CID_6847 | CID_6847 | |
| 0.069 | 0.073 | 0.187 | Carbonic anhydrase VI inhibitor | 0.187 0.015 CID_6847 | CID_6847 | |
| 0.024 | 0.028 | 0.026 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.026 0.019 CID_6847 | CID_6847 | |
| 0.01 | 0.014 | 0.019 | Lysophosphatidic acid receptor 3 agonist | 0.019 0.005 CID_6847 | CID_6847 | |
| 0.018 | 0.023 | 0.02 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.02 0.018 CID_6847 | CID_6847 | |
| 0.047 | 0.051 | 0.118 | Leukotriene B4 antagonist | 0.118 0.008 CID_6847 | CID_6847 | |
| 0.023 | 0.028 | 0.027 | Thymidine phosphorylase inhibitor | 0.027 0.017 CID_6847 | CID_6847 | |
| 0.025 | 0.031 | 0.029 | Estrogen-related receptor gamma antagonist | 0.029 0.017 CID_6847 | CID_6847 | |
| 0.031 | 0.036 | 0.037 | Ceramide glucosyltransferase inhibitor | 0.037 0.022 CID_6847 | CID_6847 | |
| 0.013 | 0.018 | 0.028 | Carbonic anhydrase VIII inhibitor | 0.028 0.005 CID_6847 | CID_6847 | |
| 0.013 | 0.018 | 0.028 | Carbonic anhydrase X inhibitor | 0.028 0.005 CID_6847 | CID_6847 | |
| 0.021 | 0.027 | 0.054 | Uridine phosphorylase inhibitor | 0.054 0.007 CID_6847 | CID_6847 | |
| 0.018 | 0.025 | 0.034 | Angiotensin AT1A receptor antagonist | 0.034 0.005 CID_6847 | CID_6847 | |
| 0.099 | 0.105 | 0.204 | Cyclooxygenase 3 inhibitor | 0.204 0.017 CID_6847 | CID_6847 | |
| 0.021 | 0.027 | 0.045 | Glutamate (mGluR1) agonist | 0.045 0.005 CID_6847 | CID_6847 | |
| 0.186 | 0.193 | 0.42 | Vasodilator, peripheral | 0.42 0.049 CID_6847 | CID_6847 | |
| 0.042 | 0.049 | 0.074 | Carbonic anhydrase IX inhibitor | 0.074 0.03 CID_6847 | CID_6847 | |
| 0.013 | 0.021 | 0.046 | Nicotinic acid receptor 1 antagonist | 0.046 0.003 CID_6847 | CID_6847 | |
| 0.014 | 0.022 | 0.017 | Telomerase stimulant | 0.017 0.013 CID_6847 | CID_6847 | |
| 0.043 | 0.053 | 0.119 | Carbonic anhydrase VB inhibitor | 0.119 0.013 CID_6847 | CID_6847 | |
| 0.075 | 0.084 | 0.085 | mTOR complex 2 inhibitor | 0.085 0.056 CID_6847 | CID_6847 | |
| 0.016 | 0.026 | 0.02 | Antibiotic Anthracycline-like | 0.02 0.012 CID_6847 | CID_6847 | |
| 0.084 | 0.094 | 0.107 | Phosphodiesterase 6D inhibitor | 0.107 0.041 CID_6847 | CID_6847 | |
| 0.036 | 0.046 | 0.05 | CF transmembrane conductance regulator antagonist | 0.05 0.009 CID_6847 | CID_6847 | |
| 0.03 | 0.041 | 0.111 | Urate transporter 1 inhibitor | 0.111 0.005 CID_6847 | CID_6847 | |
| 0.017 | 0.028 | 0.04 | NMDA receptor glycine site antagonist | 0.04 0.008 CID_6847 | CID_6847 | |
| 0.053 | 0.064 | 0.074 | Ryanodine receptor antagonist | 0.074 0.013 CID_6847 | CID_6847 | |
| 0.125 | 0.136 | 0.144 | Tumour necrosis factor antagonist | 0.144 0.108 CID_6847 | CID_6847 | |
| 0.119 | 0.13 | 0.346 | Dual specificity phosphatase 3 inhibitor | 0.346 0.021 CID_6847 | CID_6847 | |
| 0.048 | 0.06 | 0.07 | Androgen agonist | 0.07 0.03 CID_6847 | CID_6847 | |
| 0.115 | 0.127 | 0.143 | Cyclin-dependent kinase 8 inhibitor | 0.143 0.086 CID_6847 | CID_6847 | |
| 0.039 | 0.052 | 0.062 | Aldose reductase inhibitor | 0.062 0.031 CID_6847 | CID_6847 | |
| 0.037 | 0.05 | 0.044 | Dihydrofolate reductase inhibitor | 0.044 0.03 CID_6847 | CID_6847 | |
| 0.007 | 0.021 | 0.024 | Glutamate (mGluR6) agonist | 0.024 0.004 CID_6847 | CID_6847 | |
| 0.045 | 0.059 | 0.051 | Sphingosine kinase 2 inhibitor | 0.051 0.044 CID_6847 | CID_6847 | |
| 0.02 | 0.034 | 0.025 | Sodium/glucose cotransporter 2 inhibitor | 0.025 0.02 CID_6847 | CID_6847 | |
| 0.045 | 0.059 | 0.078 | Heparanase inhibitor | 0.078 0.007 CID_6847 | CID_6847 | |
| 0.127 | 0.142 | 0.283 | DNA methylase inhibitor | 0.283 0.033 CID_6847 | CID_6847 | |
| 0.017 | 0.031 | 0.024 | Prostaglandin F2 alpha agonist | 0.024 0.014 CID_6847 | CID_6847 | |
| 0.034 | 0.049 | 0.072 | Adenosine deaminase inhibitor | 0.072 0.012 CID_6847 | CID_6847 | |
| 0.024 | 0.039 | 0.036 | Epoxide hydrolase 1 inhibitor | 0.036 0.014 CID_6847 | CID_6847 | |
| 0.047 | 0.062 | 0.065 | Carbonic anhydrase stimulant | 0.065 0.036 CID_6847 | CID_6847 | |
| 0.025 | 0.041 | 0.048 | Phosphoglycerate kinase inhibitor | 0.048 0.014 CID_6847 | CID_6847 | |
| 0.042 | 0.058 | 0.049 | Protein kinase C eta inhibitor | 0.049 0.045 CID_6847 | CID_6847 | |
| 0.05 | 0.066 | 0.075 | Leukotriene C antagonist | 0.075 0.01 CID_6847 | CID_6847 | |
| 0.007 | 0.024 | 0.043 | Egl nine homolog 3 inhibitor | 0.043 0.003 CID_6847 | CID_6847 | |
| 0.054 | 0.071 | 0.14 | Carbonic anhydrase VA inhibitor | 0.14 0.013 CID_6847 | CID_6847 | |
| 0.046 | 0.062 | 0.065 | Fatty acid synthase inhibitor | 0.065 0.03 CID_6847 | CID_6847 | |
| 0.069 | 0.085 | 0.115 | Glutathione S-transferase inhibitor | 0.115 0.025 CID_6847 | CID_6847 | |
| 0.008 | 0.025 | 0.013 | Carbonic anhydrase XI inhibitor | 0.013 0.008 CID_6847 | CID_6847 | |
| 0.145 | 0.162 | 0.297 | Cyclic AMP phosphodiesterase inhibitor | 0.297 0.043 CID_6847 | CID_6847 | |
| 0.02 | 0.037 | 0.065 | Calcium-sensing receptor agonist | 0.065 0.004 CID_6847 | CID_6847 | |
| 0.029 | 0.047 | 0.056 | Integrin alpha2 antagonist | 0.056 0.008 CID_6847 | CID_6847 | |
| 0.009 | 0.027 | 0.026 | G-protein-coupled receptor 120 agonist | 0.026 0.006 CID_6847 | CID_6847 | |
| 0.131 | 0.149 | 0.274 | Non-steroidal antiinflammatory agent | 0.274 0.034 CID_6847 | CID_6847 | |
| 0.014 | 0.034 | 0.054 | Prostaglandin H2 antagonist | 0.054 0.003 CID_6847 | CID_6847 | |
| 0.02 | 0.04 | 0.042 | Integrin alpha2beta1 antagonist | 0.042 0.005 CID_6847 | CID_6847 | |
| 0.015 | 0.036 | 0.063 | Lysophosphatidic acid 1 receptor antagonist | 0.063 0.003 CID_6847 | CID_6847 | |
| 0.119 | 0.14 | 0.341 | Dual specificity phosphatase inhibitor | 0.341 0.022 CID_6847 | CID_6847 | |
| 0.037 | 0.059 | 0.056 | Aldosterone antagonist | 0.056 0.023 CID_6847 | CID_6847 | |
| 0.049 | 0.07 | 0.133 | Leukotriene antagonist | 0.133 0.013 CID_6847 | CID_6847 | |
| 0.029 | 0.051 | 0.054 | Membrane dipeptidase inhibitor | 0.054 0.013 CID_6847 | CID_6847 | |
| 0.022 | 0.043 | 0.045 | Lysophosphatidic acid 2 receptor antagonist | 0.045 0.01 CID_6847 | CID_6847 | |
| 0.032 | 0.054 | 0.037 | Thymidine kinase inhibitor | 0.037 0.035 CID_6847 | CID_6847 | |
| 0.005 | 0.028 | 0.011 | Thromboxane agonist | 0.011 0.007 CID_6847 | CID_6847 | |
| 0.014 | 0.037 | 0.076 | Leukotriene B4 receptor 2 antagonist | 0.076 0.004 CID_6847 | CID_6847 | |
| 0.016 | 0.04 | 0.022 | Isoleucine-tRNA ligase inhibitor | 0.022 0.016 CID_6847 | CID_6847 | |
| 0.014 | 0.038 | 0.023 | Caspase 8 inhibitor | 0.023 0.009 CID_6847 | CID_6847 | |
| 0.017 | 0.041 | 0.031 | Lysine carboxypeptidase inhibitor | 0.031 0.015 CID_6847 | CID_6847 | |
| 0.048 | 0.073 | 0.158 | NMDA receptor agonist | 0.158 0.007 CID_6847 | CID_6847 | |
| 0.024 | 0.049 | 0.031 | Dipeptidyl peptidase II inhibitor | 0.031 0.024 CID_6847 | CID_6847 | |
| 0.044 | 0.069 | 0.147 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.147 0.007 CID_6847 | CID_6847 | |
| 0.032 | 0.057 | 0.075 | Sphingosine 1-phosphate receptor agonist | 0.075 0.01 CID_6847 | CID_6847 | |
| 0.083 | 0.108 | 0.161 | Interleukin 1b antagonist | 0.161 0.033 CID_6847 | CID_6847 | |
| 0.013 | 0.039 | 0.02 | CXC chemokine 5 receptor antagonist | 0.02 0.008 CID_6847 | CID_6847 | |
| 0.013 | 0.039 | 0.04 | Prostaglandin E2 agonist | 0.04 0.007 CID_6847 | CID_6847 | |
| 0.015 | 0.042 | 0.033 | Neuraminidase (Influenza B) inhibitor | 0.033 0.004 CID_6847 | CID_6847 | |
| 0.016 | 0.043 | 0.024 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.024 0.016 CID_6847 | CID_6847 | |
| 0.017 | 0.044 | 0.065 | Liver X receptor beta antagonist | 0.065 0.005 CID_6847 | CID_6847 | |
| 0.008 | 0.036 | 0.019 | Aminopeptidase A inhibitor | 0.019 0.012 CID_6847 | CID_6847 | |
| 0.029 | 0.057 | 0.065 | Carbonic anhydrase XII inhibitor | 0.065 0.031 CID_6847 | CID_6847 | |
| 0.075 | 0.103 | 0.106 | MAP kinase kinase 1 inhibitor | 0.106 0.049 CID_6847 | CID_6847 | |
| 0.019 | 0.047 | 0.054 | Prostaglandin agonist | 0.054 0.009 CID_6847 | CID_6847 | |
| 0.032 | 0.061 | 0.051 | Leukotriene C4 antagonist | 0.051 0.009 CID_6847 | CID_6847 | |
| 0.043 | 0.072 | 0.06 | Glucosylceramidase inhibitor | 0.06 0.031 CID_6847 | CID_6847 | |
| 0.046 | 0.077 | 0.154 | Carbonic anhydrase V inhibitor | 0.154 0.014 CID_6847 | CID_6847 | |
| 0.046 | 0.077 | 0.056 | Sphingosine kinase inhibitor | 0.056 0.047 CID_6847 | CID_6847 | |
| 0.005 | 0.036 | 0.062 | Prostaglandin EP4 agonist | 0.062 0.004 CID_6847 | CID_6847 | |
| 0.077 | 0.108 | 0.129 | Bile acid receptor antagonist | 0.129 0.014 CID_6847 | CID_6847 | |
| 0.039 | 0.071 | 0.075 | Carbonic anhydrase inhibitor | 0.075 0.037 CID_6847 | CID_6847 | |
| 0.01 | 0.042 | 0.052 | Prostaglandin EP2 agonist | 0.052 0.005 CID_6847 | CID_6847 | |
| 0.009 | 0.042 | 0.073 | Angiotensin AT2 receptor antagonist | 0.073 0.006 CID_6847 | CID_6847 | |
| 0.035 | 0.069 | 0.082 | Diacylglycerol O-acyltransferase inhibitor | 0.082 0.013 CID_6847 | CID_6847 | |
| 0.066 | 0.101 | 0.091 | Caspase 7 inhibitor | 0.091 0.039 CID_6847 | CID_6847 | |
| 0.025 | 0.059 | 0.042 | Glutamate (mGluR4) agonist | 0.042 0.014 CID_6847 | CID_6847 | |
| 0.075 | 0.11 | 0.248 | Protein-tyrosine phosphatase 1B inhibitor | 0.248 0.017 CID_6847 | CID_6847 | |
| 0.048 | 0.084 | 0.12 | Prostaglandin-E synthase inhibitor | 0.12 0.019 CID_6847 | CID_6847 | |
| 0.023 | 0.059 | 0.048 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.048 0.01 CID_6847 | CID_6847 | |
| 0.03 | 0.066 | 0.054 | Fructose-1,6-bisphosphatase inhibitor | 0.054 0.022 CID_6847 | CID_6847 | |
| 0.029 | 0.065 | 0.043 | Glutamate (mGluR group I) agonist | 0.043 0.039 CID_6847 | CID_6847 | |
| 0.05 | 0.087 | 0.07 | Interferon inducer | 0.07 0.035 CID_6847 | CID_6847 | |
| 0.195 | 0.232 | 0.23 | DNA directed DNA polymerase inhibitor | 0.23 0.205 CID_6847 | CID_6847 | |
| 0.037 | 0.074 | 0.048 | HCV NS3/NS4A protease inhibitor | 0.048 0.036 CID_6847 | CID_6847 | |
| 0.027 | 0.065 | 0.062 | Liver X receptor alpha agonist | 0.062 0.011 CID_6847 | CID_6847 | |
| 0.101 | 0.141 | 0.337 | Protein-tyrosine phosphatase inhibitor | 0.337 0.014 CID_6847 | CID_6847 | |
| 0.06 | 0.101 | 0.096 | Myeloperoxidase inhibitor | 0.096 0.04 CID_6847 | CID_6847 | |
| 0.013 | 0.054 | 0.028 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.028 0.019 CID_6847 | CID_6847 | |
| 0.012 | 0.053 | 0.066 | Kynurenine 3 monooxygenase inhibitor | 0.066 0.005 CID_6847 | CID_6847 | |
| 0.041 | 0.083 | 0.056 | Cyclin D1 inhibitor | 0.056 0.05 CID_6847 | CID_6847 | |
| 0.058 | 0.1 | 0.087 | Interferon agonist | 0.087 0.042 CID_6847 | CID_6847 | |
| 0.018 | 0.062 | 0.042 | Cholesterol ester transfer protein antagonist | 0.042 0.011 CID_6847 | CID_6847 | |
| 0.014 | 0.058 | 0.059 | Arginase inhibitor | 0.059 0.011 CID_6847 | CID_6847 | |
| 0.029 | 0.074 | 0.059 | Carbonic anhydrase II inhibitor | 0.059 0.036 CID_6847 | CID_6847 | |
| 0.098 | 0.144 | 0.125 | Acetylcholine M1 receptor antagonist | 0.125 0.102 CID_6847 | CID_6847 | |
| 0.039 | 0.085 | 0.089 | Thromboxane synthase inhibitor | 0.089 0.009 CID_6847 | CID_6847 | |
| 0.082 | 0.128 | 0.119 | Glycogen synthase kinase-3 alpha inhibitor | 0.119 0.085 CID_6847 | CID_6847 | |
| 0.127 | 0.173 | 0.265 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.265 0.074 CID_6847 | CID_6847 | |
| 0.025 | 0.073 | 0.057 | Sphingosine 1-phosphate receptor 1 agonist | 0.057 0.014 CID_6847 | CID_6847 | |
| 0.005 | 0.052 | 0.015 | Thrombopoietin agonist | 0.015 0.005 CID_6847 | CID_6847 | |
| 0.023 | 0.071 | 0.054 | Carbonic anhydrase VII inhibitor | 0.054 0.023 CID_6847 | CID_6847 | |
| 0.017 | 0.065 | 0.05 | Glutamate (mGluR2) antagonist | 0.05 0.008 CID_6847 | CID_6847 | |
| 0.022 | 0.071 | 0.056 | Dihydropteroate synthase inhibitor | 0.056 0.013 CID_6847 | CID_6847 | |
| 0.088 | 0.137 | 0.139 | Nav1.2 sodium channel blocker | 0.139 0.065 CID_6847 | CID_6847 | |
| 0.005 | 0.055 | 0.036 | Egl nine homolog 1 inhibitor | 0.036 0.004 CID_6847 | CID_6847 | |
| 0.029 | 0.079 | 0.112 | Carbonic anhydrase XIV inhibitor | 0.112 0.008 CID_6847 | CID_6847 | |
| 0.022 | 0.072 | 0.08 | RNA-directed RNA polymerase inhibitor | 0.08 0.007 CID_6847 | CID_6847 | |
| 0.028 | 0.078 | 0.079 | Glutamate (mGluR group III) agonist | 0.079 0.013 CID_6847 | CID_6847 | |
| 0.036 | 0.087 | 0.096 | NMDA 2C receptor antagonist | 0.096 0.017 CID_6847 | CID_6847 | |
| 0.022 | 0.073 | 0.078 | Glutamate (mGluR group II) antagonist | 0.078 0.007 CID_6847 | CID_6847 | |
| 0.049 | 0.102 | 0.067 | Beta 3 adrenoreceptor antagonist | 0.067 0.039 CID_6847 | CID_6847 | |
| 0.101 | 0.155 | 0.156 | Sphingosine 1-phosphate receptor 2 antagonist | 0.156 0.034 CID_6847 | CID_6847 | |
| 0.013 | 0.068 | 0.072 | Prostaglandin EP4 antagonist | 0.072 0.005 CID_6847 | CID_6847 | |
| 0.071 | 0.127 | 0.138 | Anesthetic local | 0.138 0.055 CID_6847 | CID_6847 | |
| 0.025 | 0.082 | 0.16 | NMDA receptor subunit 3B antagonist | 0.16 0.005 CID_6847 | CID_6847 | |
| 0.002 | 0.061 | 0.008 | Insulin like growth factor 3 antagonist | 0.008 0.004 CID_6847 | CID_6847 | |
| 0.09 | 0.149 | 0.165 | Cytidine deaminase inhibitor | 0.165 0.065 CID_6847 | CID_6847 | |
| 0.034 | 0.094 | 0.044 | Bombesin 2 receptor antagonist | 0.044 0.043 CID_6847 | CID_6847 | |
| 0.024 | 0.086 | 0.066 | Carbonic anhydrase I inhibitor | 0.066 0.031 CID_6847 | CID_6847 | |
| 0.014 | 0.077 | 0.043 | Peroxisome proliferator-activated receptor delta agonist | 0.043 0.015 CID_6847 | CID_6847 | |
| 0.02 | 0.084 | 0.103 | Peroxisome proliferator-activated receptor alpha agonist | 0.103 0.012 CID_6847 | CID_6847 | |
| 0.083 | 0.147 | 0.208 | NADPH oxidase inhibitor | 0.208 0.032 CID_6847 | CID_6847 | |
| 0.016 | 0.081 | 0.09 | Farnesoid X receptor agonist | 0.09 0.004 CID_6847 | CID_6847 | |
| 0.05 | 0.115 | 0.062 | Beta 2 adrenoreceptor agonist | 0.062 0.041 CID_6847 | CID_6847 | |
| 0.017 | 0.083 | 0.132 | NMDA receptor subunit 3A antagonist | 0.132 0.006 CID_6847 | CID_6847 | |
| 0.101 | 0.166 | 0.213 | Hemostatic | 0.213 0.028 CID_6847 | CID_6847 | |
| 0.073 | 0.14 | 0.16 | Glutamate receptor antagonist | 0.16 0.044 CID_6847 | CID_6847 | |
| 0.012 | 0.08 | 0.063 | HCV NS5B polymerase inhibitor | 0.063 0.008 CID_6847 | CID_6847 | |
| 0.015 | 0.084 | 0.035 | Liver X receptor beta agonist | 0.035 0.02 CID_6847 | CID_6847 | |
| 0.071 | 0.14 | 0.146 | Nav1.3 sodium channel blocker | 0.146 0.051 CID_6847 | CID_6847 | |
| 0.054 | 0.124 | 0.155 | Protein kinase (CK2) inhibitor | 0.155 0.031 CID_6847 | CID_6847 | |
| 0.075 | 0.146 | 0.117 | Cyclooxygenase 2 inhibitor | 0.117 0.083 CID_6847 | CID_6847 | |
| 0.016 | 0.087 | 0.16 | Nicotinic acid receptor 2 agonist | 0.16 0.004 CID_6847 | CID_6847 | |
| 0.043 | 0.115 | 0.075 | Histamine H1 receptor antagonist | 0.075 0.063 CID_6847 | CID_6847 | |
| 0.01 | 0.086 | 0.026 | Beta 1 adrenoreceptor agonist | 0.026 0.011 CID_6847 | CID_6847 | |
| 0.019 | 0.095 | 0.091 | NMDA 2A receptor antagonist | 0.091 0.016 CID_6847 | CID_6847 | |
| 0.106 | 0.182 | 0.132 | MAP kinase 3 inhibitor | 0.132 0.102 CID_6847 | CID_6847 | |
| 0.029 | 0.105 | 0.058 | Neutrophil collagenase inhibitor | 0.058 0.053 CID_6847 | CID_6847 | |
| 0.089 | 0.166 | 0.238 | Cell wall synthesis inhibitor | 0.238 0.019 CID_6847 | CID_6847 | |
| 0.014 | 0.092 | 0.041 | Carbonic anhydrase IV inhibitor | 0.041 0.032 CID_6847 | CID_6847 | |
| 0.075 | 0.158 | 0.109 | Cytokine production inhibitor | 0.109 0.101 CID_6847 | CID_6847 | |
| 0.048 | 0.131 | 0.147 | NMDA receptor antagonist | 0.147 0.025 CID_6847 | CID_6847 | |
| 0.038 | 0.122 | 0.059 | Beta adrenoreceptor antagonist | 0.059 0.057 CID_6847 | CID_6847 | |
| 0.046 | 0.132 | 0.208 | Potassium channel (Ca-activated) activator | 0.208 0.013 CID_6847 | CID_6847 | |
| 0.009 | 0.096 | 0.069 | AMPA 2 receptor antagonist | 0.069 0.008 CID_6847 | CID_6847 | |
| 0.043 | 0.13 | 0.063 | Phosphodiesterase 1C inhibitor | 0.063 0.042 CID_6847 | CID_6847 | |
| 0.105 | 0.192 | 0.219 | I kappa B kinase epsilon inhibitor | 0.219 0.056 CID_6847 | CID_6847 | |
| 0.053 | 0.144 | 0.08 | Histamine H2 receptor antagonist | 0.08 0.064 CID_6847 | CID_6847 | |
| 0.103 | 0.196 | 0.349 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.349 0.004 CID_6847 | CID_6847 | |
| 0.005 | 0.098 | 0.017 | Free fatty acid receptor 1 agonist | 0.017 0.013 CID_6847 | CID_6847 | |
| 0.008 | 0.102 | 0.07 | Leukotriene B4 receptor 1 antagonist | 0.07 0.004 CID_6847 | CID_6847 | |
| 0.098 | 0.194 | 0.224 | MAP kinase kinase 2 inhibitor | 0.224 0.067 CID_6847 | CID_6847 | |
| 0.072 | 0.176 | 0.14 | Cyclooxygenase inhibitor | 0.14 0.078 CID_6847 | CID_6847 | |
| 0.01 | 0.115 | 0.111 | Retinoic acid beta receptor agonist | 0.111 0.003 CID_6847 | CID_6847 | |
| 0.148 | 0.255 | 0.332 | Antithrombotic | 0.332 0.071 CID_6847 | CID_6847 | |
| 0.03 | 0.138 | 0.048 | Beta adrenoreceptor agonist | 0.048 0.021 CID_6847 | CID_6847 | |
| 0.029 | 0.137 | 0.055 | Collagenase 3 inhibitor | 0.055 0.048 CID_6847 | CID_6847 | |
| 0.101 | 0.213 | 0.166 | Death-associated protein kinase 3 inhibitor | 0.166 0.101 CID_6847 | CID_6847 | |
| 0.049 | 0.161 | 0.165 | Protein kinase (CK2) alpha inhibitor | 0.165 0.034 CID_6847 | CID_6847 | |
| 0.003 | 0.118 | 0.081 | Retinoic acid beta receptor antagonist | 0.081 0.003 CID_6847 | CID_6847 | |
| 0.052 | 0.167 | 0.141 | Topoisomerase II inhibitor | 0.141 0.054 CID_6847 | CID_6847 | |
| 0.005 | 0.12 | 0.072 | Retinoic acid receptor gamma antagonist | 0.072 0.003 CID_6847 | CID_6847 | |
| 0.018 | 0.135 | 0.156 | Retinoic acid alpha receptor agonist | 0.156 0.003 CID_6847 | CID_6847 | |
| 0.074 | 0.192 | 0.137 | Interleukin 1 antagonist | 0.137 0.068 CID_6847 | CID_6847 | |
| 0.011 | 0.131 | 0.043 | Carnitine palmitoyltransferase inhibitor | 0.043 0.013 CID_6847 | CID_6847 | |
| 0.007 | 0.129 | 0.108 | Bombesin 3 receptor agonist | 0.108 0.003 CID_6847 | CID_6847 | |
| 0.012 | 0.135 | 0.041 | Carnitine palmitoyltransferase 1 inhibitor | 0.041 0.014 CID_6847 | CID_6847 | |
| 0.021 | 0.145 | 0.069 | Glutamate (mGluR8) antagonist | 0.069 0.004 CID_6847 | CID_6847 | |
| 0.006 | 0.131 | 0.08 | Retinoic acid alpha receptor antagonist | 0.08 0.003 CID_6847 | CID_6847 | |
| 0.086 | 0.214 | 0.145 | Neuropeptide Y1 antagonist | 0.145 0.073 CID_6847 | CID_6847 | |
| 0.042 | 0.169 | 0.069 | Heme oxygenase stimulant | 0.069 0.026 CID_6847 | CID_6847 | |
| 0.041 | 0.169 | 0.098 | Adrenaline agonist | 0.098 0.038 CID_6847 | CID_6847 | |
| 0.001 | 0.13 | 0.015 | Mannitol 2-dehydrogenase inhibitor | 0.015 0.003 CID_6847 | CID_6847 | |
| 0.127 | 0.257 | 0.322 | Transcription factor STAT3 inhibitor | 0.322 0.043 CID_6847 | CID_6847 | |
| 0.006 | 0.143 | 0.077 | Retinoic acid receptor antagonist | 0.077 0.003 CID_6847 | CID_6847 | |
| 0.008 | 0.146 | 0.128 | Bombesin agonist | 0.128 0.003 CID_6847 | CID_6847 | |
| 0.046 | 0.187 | 0.095 | Gastric antisecretory | 0.095 0.072 CID_6847 | CID_6847 | |
| 0.035 | 0.183 | 0.081 | Calcium channel L-type blocker | 0.081 0.038 CID_6847 | CID_6847 | |
| 0.01 | 0.159 | 0.037 | DNA gyrase subunit B inhibitor | 0.037 0.028 CID_6847 | CID_6847 | |
| 0.01 | 0.161 | 0.119 | NMDA 2D receptor antagonist | 0.119 0.004 CID_6847 | CID_6847 | |
| 0.102 | 0.256 | 0.155 | CC chemokine 6 receptor antagonist | 0.155 0.016 CID_6847 | CID_6847 | |
| 0.018 | 0.172 | 0.12 | Plasminogen activator inhibitor antagonist | 0.12 0.007 CID_6847 | CID_6847 | |
| 0.036 | 0.192 | 0.097 | Somatostatin 1 agonist | 0.097 0.036 CID_6847 | CID_6847 | |
| 0.005 | 0.174 | 0.098 | Retinoid X beta receptor agonist | 0.098 0.004 CID_6847 | CID_6847 | |
| 0.037 | 0.209 | 0.139 | 5-Lipoxygenase inhibitor | 0.139 0.042 CID_6847 | CID_6847 | |
| 0.009 | 0.183 | 0.049 | Retinoic acid gamma receptor agonist | 0.049 0.004 CID_6847 | CID_6847 | |
| 0.014 | 0.189 | 0.095 | NMDA 2 receptor antagonist | 0.095 0.035 CID_6847 | CID_6847 | |
| 0.009 | 0.185 | 0.041 | Retinoid X gamma receptor antagonist | 0.041 0.004 CID_6847 | CID_6847 | |
| 0.039 | 0.216 | 0.157 | Mediator release inhibitor | 0.157 0.026 CID_6847 | CID_6847 | |
| 0.075 | 0.253 | 0.211 | NOS3 expression enhancer | 0.211 0.037 CID_6847 | CID_6847 | |
| 0.067 | 0.244 | 0.276 | Diuretic | 0.276 0.027 CID_6847 | CID_6847 | |
| 0.017 | 0.198 | 0.09 | Neuraminidase (Influenza A) inhibitor | 0.09 0.004 CID_6847 | CID_6847 | |
| 0.009 | 0.193 | 0.018 | Tryptophan hydroxylase 1 inhibitor | 0.018 0.011 CID_6847 | CID_6847 | |
| 0.18 | 0.364 | 0.382 | Antiinflammatory | 0.382 0.15 CID_6847 | CID_6847 | |
| 0.008 | 0.201 | 0.125 | Retinoic acid receptor agonist | 0.125 0.004 CID_6847 | CID_6847 | |
| 0.007 | 0.207 | 0.057 | Glutamate (mGluR2) agonist | 0.057 0.012 CID_6847 | CID_6847 | |
| 0.01 | 0.214 | 0.065 | Glutamate (mGluR group II) agonist | 0.065 0.011 CID_6847 | CID_6847 | |
| 0.055 | 0.264 | 0.096 | T cell inhibitor | 0.096 0.029 CID_6847 | CID_6847 | |
| 0.015 | 0.228 | 0.166 | Peroxisome proliferator-activated receptor gamma agonist | 0.166 0.01 CID_6847 | CID_6847 | |
| 0.041 | 0.26 | 0.153 | Cyclooxygenase 1 inhibitor | 0.153 0.055 CID_6847 | CID_6847 | |
| 0.014 | 0.235 | 0.051 | Cholecystokinin B agonist | 0.051 0.016 CID_6847 | CID_6847 | |
| 0.103 | 0.33 | 0.341 | Immunosuppressant | 0.341 0.092 CID_6847 | CID_6847 | |
| 0.009 | 0.24 | 0.053 | Factor VIIa inhibitor | 0.053 0.019 CID_6847 | CID_6847 | |
| 0.005 | 0.237 | 0.095 | Retinoid X gamma receptor agonist | 0.095 0.004 CID_6847 | CID_6847 | |
| 0.009 | 0.254 | 0.158 | Purinergic P2Y14 antagonist | 0.158 0.004 CID_6847 | CID_6847 | |
| 0.024 | 0.279 | 0.134 | M18 aspartyl aminopeptidase inhibitor | 0.134 0.061 CID_6847 | CID_6847 | |
| 0.013 | 0.27 | 0.039 | Purinergic P2Y2 antagonist | 0.039 0.016 CID_6847 | CID_6847 | |
| 0.02 | 0.285 | 0.096 | CDC25A inhibitor | 0.096 0.03 CID_6847 | CID_6847 | |
| 0.022 | 0.302 | 0.083 | Bombesin 3 receptor antagonist | 0.083 0.018 CID_6847 | CID_6847 | |
| 0.008 | 0.289 | 0.169 | Prostaglandin EP2 antagonist | 0.169 0.008 CID_6847 | CID_6847 | |
| 0.052 | 0.339 | 0.309 | Hypolipemic | 0.309 0.046 CID_6847 | CID_6847 | |
| 0.079 | 0.367 | 0.145 | MAP kinase kinase 4 inhibitor | 0.145 0.072 CID_6847 | CID_6847 | |
| 0.004 | 0.296 | 0.027 | Prostaglandin EP3 antagonist | 0.027 0.024 CID_6847 | CID_6847 | |
| 0.003 | 0.308 | 0.014 | 3C-Like protease (MERS coronavirus) inhibitor | 0.014 0.005 CID_6847 | CID_6847 | |
| 0.015 | 0.321 | 0.158 | Neuraminidase (influenza) inhibitor | 0.158 0.007 CID_6847 | CID_6847 | |
| 0.016 | 0.323 | 0.077 | Sphingosine 1-phosphate receptor 5 agonist | 0.077 0.014 CID_6847 | CID_6847 | |
| 0.04 | 0.352 | 0.157 | ABCA1 expression enhancer | 0.157 0.016 CID_6847 | CID_6847 | |
| 0.005 | 0.319 | 0.037 | Prostacyclin antagonist | 0.037 0.02 CID_6847 | CID_6847 | |
| 0.056 | 0.378 | 0.191 | Sigma receptor agonist | 0.191 0.065 CID_6847 | CID_6847 | |
| 0.007 | 0.329 | 0.033 | Liver X receptor alpha antagonist | 0.033 0.015 CID_6847 | CID_6847 | |
| 0.004 | 0.329 | 0.035 | Endothelin receptor antagonist | 0.035 0.014 CID_6847 | CID_6847 | |
| 0.018 | 0.351 | 0.111 | Prostaglandin F2 alpha antagonist | 0.111 0.008 CID_6847 | CID_6847 | |
| 0.009 | 0.35 | 0.149 | Neuraminidase inhibitor | 0.149 0.006 CID_6847 | CID_6847 | |
| 0.005 | 0.354 | 0.083 | Factor VII inhibitor | 0.083 0.008 CID_6847 | CID_6847 | |
| 0.007 | 0.36 | 0.226 | Prostaglandin antagonist | 0.226 0.005 CID_6847 | CID_6847 | |
| 0.006 | 0.362 | 0.268 | Prostaglandin E2 antagonist | 0.268 0.005 CID_6847 | CID_6847 | |
| 0.004 | 0.364 | 0.029 | Cholecystokinin A agonist | 0.029 0.006 CID_6847 | CID_6847 | |
| 0.007 | 0.377 | 0.033 | Liver X receptor antagonist | 0.033 0.019 CID_6847 | CID_6847 | |
| 0.006 | 0.378 | 0.05 | Peroxisome proliferator-activated receptor delta antagonist | 0.05 0.01 CID_6847 | CID_6847 | |
| 0.028 | 0.402 | 0.084 | Breast cancer-resistant protein inhibitor | 0.084 0.073 CID_6847 | CID_6847 | |
| 0.004 | 0.405 | 0.026 | Cholecystokinin agonist | 0.026 0.01 CID_6847 | CID_6847 | |
| 0.005 | 0.419 | 0.035 | Prostaglandin D2 agonist | 0.035 0.017 CID_6847 | CID_6847 | |
| 0.024 | 0.442 | 0.117 | Adenine nucleotide translocase inhibitor | 0.117 0.004 CID_6847 | CID_6847 | |
| 0.018 | 0.44 | 0.139 | Factor IXa inhibitor | 0.139 0.004 CID_6847 | CID_6847 | |
| 0.039 | 0.474 | 0.237 | Streptokinase A inhibitor | 0.237 0.111 CID_6847 | CID_6847 | |
| 0.069 | 0.515 | 0.228 | Catenin beta inhibitor | 0.228 0.017 CID_6847 | CID_6847 | |
| 0.003 | 0.457 | 0.102 | Prostaglandin EP1 antagonist | 0.102 0.004 CID_6847 | CID_6847 | |
| 0.006 | 0.474 | 0.066 | Glutamate (mGluR) agonist | 0.066 0.04 CID_6847 | CID_6847 | |
| 0.029 | 0.512 | 0.174 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.174 0.1 CID_6847 | CID_6847 | |
| 0.056 | 0.555 | 0.259 | Lipocortins synthesis antagonist | 0.259 0.031 CID_6847 | CID_6847 | |
| 0.014 | 0.52 | 0.074 | Autotaxin inhibitor | 0.074 0.021 CID_6847 | CID_6847 | |
| 0.011 | 0.541 | 0.043 | Guanylate cyclase stimulant | 0.043 0.03 CID_6847 | CID_6847 | |
| 0.004 | 0.541 | 0.076 | Factor XI inhibitor | 0.076 0.005 CID_6847 | CID_6847 | |
| 0.009 | 0.555 | 0.085 | Leukotriene synthesis inhibitor | 0.085 0.034 CID_6847 | CID_6847 | |
| 0.005 | 0.561 | 0.117 | Factor XIa inhibitor | 0.117 0.004 CID_6847 | CID_6847 | |
| 0.003 | 0.565 | 0.045 | Somatostatin 5 antagonist | 0.045 0.015 CID_6847 | CID_6847 | |
| 0.024 | 0.591 | 0.11 | Nav1.1 sodium channel blocker | 0.11 0.056 CID_6847 | CID_6847 | |
| 0.021 | 0.603 | 0.329 | Amyloid beta precursor protein antagonist | 0.329 0.012 CID_6847 | CID_6847 | |
| 0.017 | 0.609 | 0.121 | Potassium channel large-conductance Ca-activated activator | 0.121 0.016 CID_6847 | CID_6847 | |
| 0.007 | 0.608 | 0.066 | Maillard reaction inhibitor | 0.066 0.031 CID_6847 | CID_6847 | |
| 0.009 | 0.639 | 0.073 | Nicotinic acid receptor 1 agonist | 0.073 0.012 CID_6847 | CID_6847 | |
| 0.004 | 0.642 | 0.051 | Angiotensin-converting enzyme inhibitor | 0.051 0.044 CID_6847 | CID_6847 | |
| 0.039 | 0.678 | 0.265 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.265 0.092 CID_6847 | CID_6847 | |
| 0.012 | 0.656 | 0.149 | Anticoagulant | 0.149 0.081 CID_6847 | CID_6847 | |
| 0.006 | 0.653 | 0.034 | Protein kinase C beta I inhibitor | 0.034 0.022 CID_6847 | CID_6847 | |
| 0.025 | 0.689 | 0.16 | Interleukin 4 antagonist | 0.16 0.041 CID_6847 | CID_6847 | |
| 0.068 | 0.732 | 0.174 | Peptidyltransferase inhibitor | 0.174 0.139 CID_6847 | CID_6847 | |
| 0.013 | 0.683 | 0.038 | Glucagon-like peptide 1 receptor antagonist | 0.038 0.032 CID_6847 | CID_6847 | |
| 0.004 | 0.696 | 0.037 | Protocollagen prolyl hydroxylase inhibitor | 0.037 0.009 CID_6847 | CID_6847 | |
| 0.04 | 0.732 | 0.351 | Sodium/bile acid cotransporter inhibitor | 0.351 0.039 CID_6847 | CID_6847 | |
| 0.007 | 0.725 | 0.194 | M17 leucyl aminopeptidase inhibitor | 0.194 0.035 CID_6847 | CID_6847 | |
| 0.014 | 0.735 | 0.152 | Farnesoid X receptor antagonist | 0.152 0.05 CID_6847 | CID_6847 | |
| 0.014 | 0.757 | 0.146 | P-glycoprotein inhibitor | 0.146 0.124 CID_6847 | CID_6847 | |
| 0.021 | 0.786 | 0.46 | Cyclophilin D inhibitor | 0.46 0.063 CID_6847 | CID_6847 | |
| 0.028 | 0.794 | 0.1 | Folate antagonist | 0.1 0.064 CID_6847 | CID_6847 | |
| 0.009 | 0.776 | 0.148 | Thrombolytic | 0.148 0.083 CID_6847 | CID_6847 | |
| 0.021 | 0.789 | 0.265 | Hypoglycemic | 0.265 0.068 CID_6847 | CID_6847 | |
| 0.007 | 0.783 | 0.061 | Myc inhibitor | 0.061 0.028 CID_6847 | CID_6847 | |
| 0.048 | 0.835 | 0.261 | Interleukin 2 agonist | 0.261 0.107 CID_6847 | CID_6847 | |
| 0.008 | 0.809 | 0.051 | DNA gyrase subunit A inhibitor | 0.051 0.016 CID_6847 | CID_6847 | |
| 0.015 | 0.838 | 0.121 | DNA polymerase I inhibitor | 0.121 0.067 CID_6847 | CID_6847 | |
| 0.005 | 0.829 | 0.184 | Platelet antagonist | 0.184 0.114 CID_6847 | CID_6847 | |
| 0.018 | 0.849 | 0.079 | Hematopoietic | 0.079 0.077 CID_6847 | CID_6847 | |
| 0.008 | 0.849 | 0.059 | Carnitine palmitoyltransferase 1B inhibitor | 0.059 0.018 CID_6847 | CID_6847 | |
| 0.008 | 0.88 | 0.236 | Insulin secretagoues | 0.236 0.022 CID_6847 | CID_6847 | |
| 0.005 | 0.885 | 0.124 | Chelator | 0.124 0.05 CID_6847 | CID_6847 | |
| 0.004 | 0.899 | 0.09 | Cell adhesion molecule inhibitor | 0.09 0.043 CID_6847 | CID_6847 | |
| 0.004 | 0.93 | 0.091 | DNA gyrase inhibitor | 0.091 0.021 CID_6847 | CID_6847 | |
| 0.005 | 0.946 | 0.133 | Cell adhesion inhibitor | 0.133 0.057 CID_6847 | CID_6847 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |